Blood pressure (BP) control of type 2 diabetic subjects aged under 65 years was assessed in a primary care setting. In addition, the usefulness of 24-h ambulatory BP measurement (ABPM) in the treatment of hypertension was assessed in subjects with diastolic BP (DBP) у90 mm Hg. Of the total 381 diabetic subjects, 260 (68%) participated in the first phase, and 48 of the 110 subjects with DBP у90 mm Hg were equipped with a Meditech ABPM-02 monitor in the second phase. The mean BP of the 260 participants was 156/91 (s.d. 22/11) mm Hg. According to the WHO criteria, 58% had hypertension, and 42% had a diagnosis of hypertension. Albuminuria у20 g/min was detected in 32% of the subjects. Ten percent of the subjects with diagnosed hypertension
Introduction
Elevated blood pressure (BP) is known to be a major risk factor for mortality and complications in subjects with type 2 diabetes. This has been demonstrated in recent large prospective HOT and UKPDS studies. 1, 2 These studies revealed that adequate BP control not only reduced markedly microvascular complications, but also overall and cardiovascular mortality. From 38 to 66% of newly diagnosed type 2 diabetic patients have hypertension. 1, 3 The UK Prospective Diabetes Study emphasised that reducing BP has a high priority in type 2 diabetes care. 1 It has been stated, that BP control is poor in hypertensive subjects. [4] [5] [6] In a recent Finnish study of hypertension care, good BP control (Ͻ140/90 mm Hg) was achieved in 11% of hypertensive subjects and acceptable control (Ͻ160/95 mm Hg) in 40% of 3520 hypertensive subjects treated in primary health care. 4 Other studies have shown similar treatment outcomes. 5, 6 The BP control has not been a major outcome in diabetes care audits. 7, 8 An elevated urinary albumin excretion rate (UAER) has been associated with increased mortality in subjects with type 2 diabetes. [9] [10] [11] On the other hand, high BP has increased the UAER in pro- had a mean BP Ͻ140/90 mm Hg and 50% had a mean BP у160/95 mm Hg, as many as 38% of those not having a diagnosis of hypertension. Only long-term poor BP control in casual measurements was associated with albuminuria (42% vs 27%, P ‫؍‬ 0.018). It is concluded that BP control was unsatisfactory and diagnosis of hypertension was delayed in most subjects with type 2 diabetes. Occurrence of microalbuminuria was associated with poor BP control and urinary albumin excretion rate may be useful in assessing the BP control. Further studies are needed to assess the position of 24-h ABPM in the treatment of hypertension of subjects with type 2 diabetes. Journal of Human Hypertension (2000) 14, 111-115 spective studies. [12] [13] [14] In 24-h ambulatory BP measurement (ABPM), those with white coat hypertension have had a decreased UAER 15, 16 and more of those with an increased UAER have had the nondipper phenomenon, 17 which supports the hypothesis that BP control is associated with urinary albumin excretion. Of the hypertensive type 2 diabetic subjects, 8-23% have white coat hypertension 16 and 30-31% show the non-dipper phenomenon. 18 The 24-h ABPM could be useful in the treatment of hypertension of subjects with type 2 diabetes to detect the ones with white coat hypertension (lowrisk) and the non-dipper phenomenon (high-risk).
The problem is that a great number of diabetic subjects have unsatisfactory BP control in casual measurements. As the elevated UAER is associated with higher BP, it could be used as an indicator of BP control. The aim of the present study was to assess BP control, and to test the usefulness of 24-h ABPM in the management of hypertension of subjects with type 2 diabetes.
Materials and methods
The subjects of this study were type 2 diabetic patients under 65 years of age in the area served by the health centre of Mikkeli, in eastern Finland. There were a total of 53 000 inhabitants, of which 42 000 were under 65 years old. Subjects with type 2 diabetes were identified with repeated fasting blood glucose у6.7 mmol/l and/or type 2 diabetes dia-gnosis. The formation of the study population has been decribed previously. 8 The study was carried out from December 1992 to January 1994. Authorization for the study was provided by the ethical committee of the University Hospital of Kuopio. Data for age, gender, number of checkups, initial hypertension, antihypertensive agents and initial coronary heart disease were checked on a questionnaire supplemented from patient records. BP level was determined with up to five previous (during the last 2 years) BP measurements. In the health centre, BP was measured from the right arm with a standard mercury sphygmomanometer by a trained nurse after at least 10 min rest. Hypertension was defined as mean BP у160/95 and/or antihypertensive treatment according to WHO criteria. 19 Good, satisfactory and poor BP control was defined according to the guidelines. 20 Up to three fasting blood glucose values (during the previous 2 years) were obtained from patient records and the mean of these values was used as a measure of blood glucose. In the clinical examination, body mass index (BMI) was measured and fasting blood sample was obtained to measure glycated haemoglobin A 1c (HbA 1c ), total cholesterol, high density lipoprotein (HDL) cholesterol and triglycerides. An overnight (12 h) urine sample was collected and albumin excretion rate was determined. A single value у20 g/min was regarded as albuminuria. Laboratory methods have been presented previously in detail. 8 Those subjects with mean diastolic BP (DBP) у90 mm Hg were asked to participate in the 24-h ABPM. This was performed with the Meditech ABPM-02 24-h fully-automatic, portable ambulatory BP monitor, which has been validated in 1994. According to the criteria of British Hypertension Society, it has been graded C for both diastolic and systolic values against standard zero and C for systolic (SBP) and B for diastolic (DBP) against random zero sphygmomanometer. 21 The device was set to record BP reading at 20-min intervals between 7.00 am and 11.00 pm and at 40-min intervals during the night. Recordings were always started at 7.00 am and the subjects carried on with their normal daily activities during the 24-h measurement. The data were analysed to calculate mean office time (8.00 am to 4.00 pm), daytime (7.00 am to 11.00 pm) and night-time (11.00 pm to 7.00 am) BP values and daytime and night-time mean arterial pressures (MAP).
White coat hypertension was defined as mean office time BP Ͻ85 mm Hg in 24-h ABPM and DBP у90 mm Hg in casual measurements. The non-dipper phenomenon was defined as Ͻ5 mm Hg mean DBP decrease in night-time DBP compared to daytime DBP.
The study population was followed for 5 years (September 1992 to September 1997) and those who had died during the 5-year period were identified in September 1997. Those who had moved during the follow-up period were excluded from further analyses.
Statistical analyses were performed with SAS and BMDP statistical software in the University of Oulu. For nominal and ordinal variables, chi-square test was used. For interval and ratio variables, two-tailed Student's t-test and Wilcoxon test were used when appropriate. Survival rates were examined with Cox regression analysis. To analyse how great differences in the UAER are detectable based on the ABPM data with 90% degree of power, a logarithmic transformation of UAER variable was performed (to make it normally distributed) and the difference was calculated from the formula
where ␦ = differences in urinary albumin excretion rate, = standard deviation, n = sample size, ␣ = Pvalue and ␤ = degree of power, and Z 1−␣/2 is a 1−␣/2 fractile of normal distribution curve. The difference in the urinary albumin excretion rate was estimated by the 10 1±␦ (anti Ig) in the ABPM groups with the approximation that the median urinary albumin excretion rate was 10 1 = 10 g/min.
Results
Of the 381 subjects aged under 65 years identified with type 2 diabetes, 260 (68%) took part in the study. The loss of the subjects has been described in detail previously. 16 In the total study population, the mean age was Figure 1 shows the proportions of subjects with good (Ͻ140/90 mm Hg), satisfactory (140-159/90-94 mm Hg) and poor (у160/95 mm Hg) BP control in those with and those without a diagnosis of hypertension. Of all 260 subjects, 152 (58%) had hypertension according to the WHO criteria, 49 (19%) of these had not previously been diagnosed as being hypertensive. With respect to those previously diagnosed as being hypertensive, one out of 10 had good but one in two had poor BP control, and of those not previously diagnosed, every fourth had good and every third had poor BP control. Only every fifth of all diabetic subjects was in good BP control.
BP measurements had been registered at least once in the previous 2 years in 233 (90%) subjects; in 98% of those with a diagnosis of hypertension and in 85% of those without this diagnosis. At least two measurements each year had been carried out in only 68% of subjects. In the subjects diagnosed as being hypertensive, 61% were on monotherapy, and 8% had three or more antihypertensive agents; 46% used angiotensin-converting enzyme (ACE) inhibitors, 39% used beta-blockers, 31% used calcium antagonists and 31% used diuretics.
In Table 1 , the study population (the eight subjects who had moved have been excluded) was classified according to DBP under and equal or over 90 mm Hg in previous casual measurements. Those with elevated DBP were younger, clearly more obese and they had higher serum triglycerides and had a higher prevalence of albuminuria (42% vs 27%). There were no differences in other parameters or in 5-year mortality between these two groups.
Of these 110 subjects with mean DBP у90 mm Hg, 48 (44%) participated in the 24-h ABPM. The nonparticipants differed from the participants in that they had a longer duration of diabetes (median 8 vs 
-test).
There were no differences in age, BMI, lipid values, UAER, initial hypertension, coronary heart disease or 5-year mortality between the participant and non-participant groups.
In Table 2 , the results of the 24-h ABPM are shown. The mean daytime BP was 21/6 mm Hg lower in ABPM compared with casual measurements. White coat hypertension was diagnosed in 8/48 (17%) and non-dipper phenomenon in 18/47 (38%) of the hypertensive diabetic subjects. One of the participants had both white coat hypertension and non-dipper phenomenon. Those with white coat hypertension had the lowest mean BP in 24-h ABPM and their mean daytime BP was 33/18 mm Hg lower compared with casual measurements. Of the non-dippers, 12/18 (67%) had higher MAP during the night than during the daytime. One ABPM recording failed to provide night-time BP values. Two participants died during the follow-up, and they both had sustained hypertension. No survival analyses were performed.
There were no differences in lipid values, BMI, albuminuria or initial coronary heart-disease between subjects with white coat and those with sustained hypertension, and between non-dippers and dippers. Those with white coat hypertension tended to have a shorter duration of diabetes (P = 0.007, Wilcoxon) and less often had a diagnosis of hypertension (P = 0.06, chi-square). On the contrary, those with non-dipper phenomenon tended to have a longer duration of diabetes (P = 0.02) and also were more often likely to have been diagnosed as being hypertensive (P = 0.07).
The calculation of statistical power to reveal significant differences in UAER in relation to the sample size is shown in Figure 2 . With logarithmic transformation of the UAER variable, the mean was 1.13, median 1.08, s.d. 0.62 and variance 0.38. It could be estimated that these data could have revealed a 8 g/min UAER decrease in the subjects with white coat hypertension and a 30 g/min UAER increase in those with the non-dipper phenomenon with 90% degree of power and a 95% confidence level.
Discussion
Hypertension was very common and BP control was unsatisfactory in subjects with type 2 diabetes, which is in line with previous studies. 3,4 -6 Of the hypertensive subjects, only 10% had good BP control and 50% had poor BP control. There may be several reasons for this unsatisfactory outcome. Firstly, elevated BP had not been detected, since one-third of subjects with poor BP control did not have a diagnosis of hypertension. In Finland, a mean DBP Ͼ95 mm Hg has been the criterion for 75% reimbursement (instead of 50%) of the costs of antihypertensive drugs for diabetic subjects from the Social Security Institute, which may have influenced the initiation of antihypertensive agents. Secondly, antihypertensive treatment was inadequate, since most hypertensive subjects were on monotherapy. 2 Casual BP measurements had been performed twice a year in two-thirds of the subjects, which is far less than the recommended frequency. 20 The other main result was that UAER can be used as an indicator of BP control. Long-term poor BP control in casual measurements was associated with albuminuria, which agrees with the previous studies. [12] [13] [14] In the present study, no differences in 5-year mortality were found, which was probably due to the small number of the study population and the short follow-up time. 22 The participation rate was low in the 24-h ABPM. This measurement required two visits to the health centre and the inconvienience of wearing the device for 24 h. The non-participants were more often men and those with mild hypertension, which may underestimate the prevalence of white coat hypertension. The results showed that the compliance of patients to participate in the ABPM was not very high. Further, it has been shown that several ambulatory BP measurements are needed to get reliable results. 23 In the present study, the sample size was too low to reveal the possible differences in the between those with white coat hypertension and those with the non-dipper phenomenon compared with those with sustained hypertension.
In our study population, the prevalence of white coat hypertension and the non-dipper phenomenon were similar to the previous studies. 16, 18 Our results suggest that white coat hypertension may represent the first stage in the development of hypertension. Two participants died during the follow-up, and no conclusion can be drawn from the mortality.
It can be concluded that BP control was unsatisfactory in most subjects with type 2 diabetes. The frequency of casual BP measurements could well be increased and the decision to initiate antihypertensive treatment should be based on these measurements. Education for doctors is needed if one wishes to achieve earlier diagnosis of hypertension and more aggressive antihypertensive treatment. Occurrence of microalbuminuria was associated with poor BP control in long-term casual measurements and UAER may be useful in assessing the BP control. Further studies with greater sample sizes are needed to assess the position of 24-h ABPM in care of hypertensive subjects with type 2 diabetes.
